Feeds › Merger clearances (HSR)
Merger clearances (HSR)
Mergers and acquisitions the FTC and Justice Department cleared early under the Hart-Scott-Rodino Act, with the public companies among them. Granted requests only.
About this data
- What it is
- Companies planning a merger or acquisition above a size threshold must tell the FTC and the Justice Department first and wait 30 days before closing (the Hart-Scott-Rodino Act). The parties can ask for that wait to end early, and when the agencies agree, the FTC publishes an early termination notice. This feed lists those notices: the buyer, the target, the entities being acquired and the day early termination was granted. We match each name to a public company when it lines up.
- Who files it
- The FTC, which publishes a notice once it and the Department of Justice have granted the request.
- How current
- We check the FTC's list every day. A notice is published when early termination is granted, which is before the deal closes.
- Terms
- Hart-Scott-RodinoThe Hart-Scott-Rodino Act requires companies planning a merger or acquisition above a size threshold to tell the FTC and the Justice Department first and wait 30 days before closing, so the agencies can look for competition problems.Early terminationThe parties can ask for that waiting period to end sooner. When the agencies agree, the FTC publishes an early termination notice. It means the deal was cleared to close early, not that the agencies endorse it.Possible matchWe match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.
- Worth knowing
- This is a partial list of deals, not every merger. Only requests that were granted appear: deals that waited out the full 30 days, deals whose request was refused and deals that were never reportable are not listed. The FTC granted no early terminations from February 2021 until the new HSR form took effect in February 2025, so there is nothing between those dates. A notice does not mean the agencies endorse a deal, and it does not say whether the deal closed. Most buyers and targets are private companies, funds or people. We match names to public companies automatically; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly.
This comes from the FTC's list of early-termination notices.
Source and freshness · Information, not investment advice (disclaimer).
Early terminations granted per month, last 24 months
Only granted requests are listed, not every deal. The FTC granted none from February 2021 until the new HSR form took effect in February 2025.
Latest early terminations granted
Showing: ticker NVS
Only early terminations that were granted are listed, not every deal, and none were granted between February 2021 and February 2025.
| Granted | BuyerThe "acquiring person" in the filing: the ultimate parent entity of the buyer, which can be a company, a fund or a person. We match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match. | TargetThe "acquired person": the ultimate parent entity of the target. The entities actually being acquired are listed under it. | Transaction | Source |
|---|---|---|---|---|
| Nov 9, 2026 | Novartis AG | Bo Ying Suzhou Abogen Biosciences Co., Ltd; Abogen Life Sciences (Shanghai) C… | 20270118 | FTC ↗ |
| Aug 4, 2026 | Novartis AG | Myricx Pharma Limited | 20261873 | FTC ↗ |
| Apr 30, 2026 | Novartis AG | Red Tree Venture Fund, L.P. Excellergy, Inc. | 20261253 | FTC ↗ |
| Dec 17, 2025 | Novartis AG | Avidity Biosciences, Inc. | 20260351 | FTC ↗ |
| Dec 18, 2019 | Novartis AG | The Medicines Company | 20200376 | FTC ↗ |
| Nov 20, 2019 | Novartis AG | Pliant Therapeutics, Inc. | 20200172 | FTC ↗ |
| Mar 18, 2019 | Clinigen Group plc | Novartis AG Novartis Vaccines and Diagnostics, Inc. | 20190868 | FTC ↗ |
| Feb 21, 2019 | Novartis AG | Ionis Pharmaceuticals, Inc. Akcea Therapeutics, Inc. | 20190748 | FTC ↗ |
| Aug 20, 2018 | Mylan N.V. | Novartis AG Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG | 20181750 | FTC ↗ |
| Jan 3, 2018 | Novartis AG | Ultragenyx Pharmaceutical Inc. | 20180490 | FTC ↗ |
| Dec 8, 2017 | Novartis AG | BioMarin Pharmaceutical Inc. BioMarin Commerical Limited | 20180356 | FTC ↗ |
| Apr 14, 2017 | Novartis AG | Lubris, LLC | 20171009 | FTC ↗ |
| Feb 8, 2017 | Sun Pharmaceutical Industries Ltd. | Novartis AG Novartis Pharma AG | 20170582 | FTC ↗ |
| Jan 12, 2017 | Novartis AG | Encore Vision, Inc. | 20170496 | FTC ↗ |
| Jan 12, 2017 | Novartis AG | Ziarco Group Limited | 20170458 | FTC ↗ |
| Nov 7, 2016 | Novartis AG | Selexys Pharmaceuticals Corporation | 20170123 | FTC ↗ |
| Mar 10, 2016 | Novartis AG | Transcend Medical, Inc. | 20160787 | FTC ↗ |
| Jul 27, 2015 | HLS Therapeutics Inc. | Novartis AG Novartis Pharmaceuticals Corporation; Novartis Pharma AG | 20151316 | FTC ↗ |
| Jul 21, 2015 | Novartis AG | Spinifex Pharmaceuticals, Inc. | 20151262 | FTC ↗ |
| Dec 19, 2014 | Eli Lilly and Company | Novartis AG | 20140956 | FTC ↗ |
| Nov 26, 2014 | GlaxoSmithKline plc | Novartis AG Novartis Vaccines and Diagnostics Pty Ltd; Novartis Vaccines and Diag… and 8 more | 20141013 | FTC ↗ |
| Oct 10, 2014 | Novartis AG | WaveTec Vision Systems, Inc. | 20141558 | FTC ↗ |
| Aug 11, 2014 | Novartis AG | Google Inc. Google Asia Pacific Pte. Ltd.; Google Ireland Limited | 20141355 | FTC ↗ |
| Dec 17, 2013 | Grifols, S.A. | Novartis AG Novartis Pharma AG; Novartis Vaccines and Diagnostics Pty Ltd and 3 more | 20140219 | FTC ↗ |
| Jul 13, 2012 | Novartis AG | Fougera S.C.A. SICAR Fougera Holdings Inc. | 20120837 | FTC ↗ |
| May 4, 2011 | Meda AB (publ) | Novartis AG Novartis Pharmaceuticals Corporation | 20110755 | FTC ↗ |
| Feb 4, 2011 | Novartis AG | Genoptix, Inc Genoptix, Inc. | 20110518 | FTC ↗ |
| Oct 12, 2010 | Warner Chilcott plc | Novartis AG Novartis Pharma AG; Novartis Pharmaceuticals Corporation | 20101185 | FTC ↗ |
| Aug 17, 2010 | Novartis AG | Nestle S.A. Alcon, Inc. | 20100346 | FTC ↗ |
| Jun 19, 2009 | Novartis AG | Schering-Plough Corporation Schering-Plough Ltd. | 20090487 | FTC ↗ |
| Jun 19, 2009 | Schering-Plough Corporation | Novartis AG Novartis Pharma AG | 20090486 | FTC ↗ |
| Nov 18, 2008 | Novartis AG | Nektar Therapeutics | 20090096 | FTC ↗ |
| Jun 1, 2007 | Novartis AG | Antisoma plc Antisoma Research Limited | 20071293 | FTC ↗ |
| Apr 30, 2007 | Bayer AG | Novartis AG Novartis Vaccines and Diagnostics, Inc. | 20071105 | FTC ↗ |
| Oct 16, 2006 | Novartis AG | Cell Therapeutics, Inc. Cell Therapeutics Europe S.r.l. | 20061867 | FTC ↗ |
| Aug 31, 2006 | Novartis AG | Momenta Pharmaceuticals, Inc. | 20061562 | FTC ↗ |
| Dec 12, 2005 | Novartis AG | Takeda Pharmaceuticals Company, Ltd. TAK possible match TAP Pharmaceutical Products Inc. | 20060251 | FTC ↗ |
| Dec 12, 2005 | Novartis AG | Abbott Laboratories TAP Pharmaceutical Products Inc. | 20060250 | FTC ↗ |
| Dec 5, 2005 | Novartis AG | Chiron Corporation | 20060211 | FTC ↗ |
| Aug 16, 2005 | Novartis AG | Bristol Myers Squibb Company | 20051327 | FTC ↗ |
| Jul 19, 2005 | Novartis AG | Santo Holding AG Eon Labs, Inc. | 20050702 | FTC ↗ |
| Apr 15, 2003 | Novartis AG | Idenix Pharmaceuticals, Inc. | 20030494 | FTC ↗ |
| Apr 8, 2003 | Novartis AG | Pfizer, Inc. | 20030482 | FTC ↗ |
| Jan 31, 2003 | Watson Pharmaceuticals, Inc. | Novartis AG Novartis Pharma AG; Novartis Pharmaceuticals Corporation | 20030286 | FTC ↗ |
| Nov 22, 2002 | Guidant Corporation | Novartis AG | 20030088 | FTC ↗ |
| Aug 24, 2001 | Novartis AG | Novo Nordisk A/S | 20012292 | FTC ↗ |
| Jul 30, 2001 | Novartis AG | Dr. Reddy's Laboratories Limited | 20012106 | FTC ↗ |
| Jun 7, 2001 | Tyco International, Ltd. | Novartis AG Novartis Corporation | 20011859 | FTC ↗ |
| Nov 14, 2000 | Novartis AG | Orion Corporation | 20010280 | FTC ↗ |
| Sep 29, 2000 | Novartis AG | Wesley Jessen VisionCare, Inc. | 20003720 | FTC ↗ |
The newest 50 items, most recent first. Each row links to the FTC page that lists the notices; the transaction number identifies it there. Updated Nov 15, 2026, 5:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances